Seong-Chul Kim
Director/Miembro de la Junta en KPS CORPORATION .
Fortuna: 3 M $ al 30/04/2024
Perfil
Seong-Chul Kim is the founder of Elevar Therapeutics, Inc. which was founded in 2005.
He held the titles of President, Chief Executive Officer & Director.
Currently, he is a Director at KPS Corp.
(South Korea) where he still holds a job.
In the past, he worked as Co-Chief Executive Officer at LSK Investment Co. Ltd.
from 2016 to 2018 and as Director & Head-Bio at HLB Co., Ltd.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
KPS CORP
2.94% | 03/04/2024 | 550 458 ( 2.94% ) | 3 M $ | 30/04/2024 |
Cargos activos de Seong-Chul Kim
| Empresas | Cargo | Inicio |
|---|---|---|
| KPS CORPORATION | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Seong-Chul Kim.
| Empresas | Cargo | Fin |
|---|---|---|
LSK Investment Co. Ltd.
 LSK Investment Co. Ltd. Investment ManagersFinance LSK Investment Co. Ltd. (LSK Investment), a private equity & venture capital subsidiary of HLB Life Science Co Ltd., was founded in 2016. The firm is headquartered in Seoul, South Korea. | Director Ejecutivo | 31/12/2018 |
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Fundador | - |
| HLB CO., LTD. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| HLB CO., LTD. | Health Technology |
| KPS CORPORATION | Electronic Technology |
| Empresas privadas | 2 |
|---|---|
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
LSK Investment Co. Ltd.
LSK Investment Co. Ltd. Investment ManagersFinance LSK Investment Co. Ltd. (LSK Investment), a private equity & venture capital subsidiary of HLB Life Science Co Ltd., was founded in 2016. The firm is headquartered in Seoul, South Korea. | Finance |
- Bolsa de valores
- Insiders
- Seong-Chul Kim